• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Information chapters in pharmacopoeias.

作者信息

Banes D

出版信息

Ann Ist Super Sanita. 1975;11(3-4):290-5.

PMID:1234730
Abstract

Pharmacopoeias have been established by governmental authorities to serve three primary purposes: 1) to compile a select list of currently utilized drugs, including the most efficient forms for their application; 2) to distinguish these articles by convenient and definite names; and 3) to publish objective standards and analytical methods suitable for testing the integrity of commercially available preparations. In addition, some pharmacopoeias also offer informational text intended to instruct pharmacists on the compounding, use, storage and labeling of drugs; to advise physicians about dosage regimens and preferred modes of administration; to counsel producers about good manufacturing practices, and to edify drug analysts by explaining the theories underlying methods employed in compendial tests and assays. Examples of informational chapters in USP XIX are those on Pharmaceutical Dosage Forms, Stability Considerations in Dispensing Practice, and Sterilization. Because of the official status of national pharmacopoeias and their use as regulatory instruments in drug control, pharmacopoeial text intended merely for the information of the reader should be identified as such, and should be separated and distinguished from the mandatory, legally enforceable requirements.

摘要

相似文献

1
Information chapters in pharmacopoeias.
Ann Ist Super Sanita. 1975;11(3-4):290-5.
2
Design and international harmonization of pharmacopoeial standards.药典标准的设计与国际协调。
J Pharm Biomed Anal. 1995 Dec;14(1-2):1-5. doi: 10.1016/0731-7085(95)01578-7.
3
Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.美国药典第<71>章无菌检查的实验室考量及其在药物配制中的应用。
Int J Pharm Compd. 2014 Jan-Feb;18(1):46-52.
4
Pharmacopoeia as quality codex for the manufacturers.药典作为制造商的质量法典。
Ann Ist Super Sanita. 1975;11(3-4):269-80.
5
WHO Expert Committee on specifications for pharmaceutical preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 1996;863:1-194.
6
WHO Expert Committee on Specifications for Pharmaceutical Preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 1999;885:i-vi, 1-156.
7
USP general chapter <797> pharmaceutical compounding-sterile preparations.美国药典通则<797>章 药物配制-无菌制剂
J Nucl Med. 2004 Jun;45(6):20N, 28N.
8
Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.美国药典官方参考标准:计量学概念、概述以及科学问题与机遇。
J Pharm Biomed Anal. 2006 Jan 23;40(1):3-15. doi: 10.1016/j.jpba.2005.07.017. Epub 2005 Nov 21.
9
The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.美国药典通则<797>对无菌放射性药物制备程序和要求的潜在影响。
J Nucl Med. 2004 Jun;45(6):21N-6N.
10
International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice.国际协调会议;关于在国际协调会议区域使用的药典文本的Q4B评估和建议的指南;非无菌产品微生物检验的附录4C:药用制剂和药用物质通则的验收标准;可用性。通知。
Fed Regist. 2009 Apr 8;74(66):15992-3.